newsfilter
← Latest News
GlobeNewswire·

Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences

SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell